Updates on campus events, policies, construction and more.
close  
Whether you are part of our community or are interested in joining us, we welcome you to Washington University School of Medicine.
close  
Search

PLoS publishes a collection of DOLF research on lymphatic filariasis
July 7, 2022
The foot of a person on the island of Flores in Indonesia is massively swollen due to lymphatic filariasis. Washington University’s Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Project has been recognized with a Public Library of Science (PLoS) collection of publications.
The work of Washington University’s Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Project, which performs research in support of global efforts to eliminate neglected tropical diseases, has been recognized with a Public Library of Science (PLoS) collection of publications. The DOLF Project is co-led by Peter U. Fischer, PhD, a professor of medicine, and Gary J. Weil, MD, the Gerald & Judith Medoff Professor of Infectious Diseases and a professor of medicine and of molecular microbiology, both at Washington University School of Medicine in St. Louis.
About 800 million people worldwide are at risk of developing lymphatic filariasis, also known as elephantiasis, a disfiguring and disabling mosquito-borne worm infection that causes massive swelling in the legs, feet and scrotum. The collection contains 11 articles by the DOLF Project on the safety, efficacy and acceptability of mass administration of a triple-drug combination known as IDA (ivermectin, DEC and albendazole) for lymphatic filariasis.
Data from these studies informed the World Health Organization (WHO) decision to endorse IDA in 2017 and extend drug donations by pharmaceutical companies. Tens of millions of people now receive the triple-drug combination each year, accelerating progress toward the WHO’s goal of eliminating the disease as a public health problem worldwide by 2030.
Media Contact
Tamara Bhandari
Senior Medical Science Writer
314-286-0122
[email protected]
June 27, 2022
‘This is an occasion for gratitude, immense gratitude’.
News Release
June 27, 2022
Molecule liberated from byproduct of juice manufacturing has positive effects on metabolism.
News Release
June 8, 2022
Faster diagnosis could help limit deadly outbreaks.
News Release
660 S. Euclid Ave., St. Louis, MO 63110-1010
Consistently ranked a top medical school for research, Washington University School of Medicine is also a catalyst in the St. Louis biotech and startup scene. Our community includes recognized innovators in science, medical education, health care policy and global health. We treat our patients and train new leaders in medicine at Barnes-Jewish and St. Louis Children’s hospitals, both ranked among the nation’s best hospitals and recognized for excellence in care.

source